NCT04289077 - Quality of Life of Patients With Desmoid-type Fibromatosis | Biotech Hunter

Enrollment

156

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions

Desmoid TumorDesmoid-type Fibromatosis

Interventions

OTHER

Questionnaires

\- Baseline questionnaire, version 1.0, October 29 2019, (Dutch) - Health care utilization, version 1.0, October 29 2019, (Dutch) - Decision-making, version 1.0, October 29 2019, (Dutch) - EORTC QLQ-C30, version 3.0, (Dutch) - DTF-QoL, version 1.0, October

Trial Locations (4)

1066 CX

3. Antoni van Leeuwenhoek Ziekenhuis (AVL) / The Netherlands Cancer Instituut , Amsterdam, The Netherlands, Amsterdam

6525 GA

Radboud University Medical Center (MC), Nijmegen, The Netherlands, Nijmegen

3015 GD

Erasmus MC Cancer Institute, Rotterdam

SW3 6JJ

Royal Marsden NHS Foundation Trust, London